Frankfurt - Delayed Quote EUR
ACADIA Pharmaceuticals Inc. (DR6.F)
13.02
+0.26
+(2.04%)
At close: April 25 at 8:54:38 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 16 | 15 | 20 | 18 |
| Avg. Estimate | 238.49M | 263.76M | 1.06B | 1.17B |
| Low Estimate | 224.78M | 249.7M | 1.01B | 1.09B |
| High Estimate | 253M | 273.63M | 1.09B | 1.35B |
| Year Ago Sales | 205.83M | 241.96M | 957.8M | 1.06B |
| Sales Growth (year/est) | 15.87% | 9.01% | 10.83% | 9.99% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DR6.F | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 2/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/27/2025 |
| Reiterates | Needham: Buy to Buy | 2/27/2025 |
| Initiated | Deutsche Bank: Hold | 2/11/2025 |
| Downgrade | Guggenheim: Buy to Neutral | 1/3/2025 |
Related Tickers
IKAP.F Aurinia Pharmaceuticals Inc.
7.06
+0.97%
NKB2.F TG Therapeutics, Inc.
35.26
+2.63%
9606.HK Duality Biotherapeutics, Inc.
207.400
-7.82%
KZR Kezar Life Sciences, Inc.
4.7000
-1.05%
INZY Inozyme Pharma, Inc.
0.9842
+2.52%
MTSR Metsera, Inc.
18.53
-12.51%
ALLO Allogene Therapeutics, Inc.
1.5500
-1.27%
DNLI Denali Therapeutics Inc.
15.68
+1.23%
4147.TWO TaiMed Biologics Inc.
80.00
+0.50%
REGN Regeneron Pharmaceuticals, Inc.
602.64
+0.48%